Results 121 to 130 of about 449,349 (233)
Hepatocellular cancer (HCC) remained a life-threatening carcinoma. Agents for HCC imaging and therapy were expected to possess different intratumoral retention time.
Xinmiao Lu +5 more
doaj +1 more source
[18F]Talazoparib: a novel potential PET imaging agent of PARP
Riccardo Muzzioli +4 more
openaire +1 more source
Evaluation of 64Cu-based radiopharmaceuticals that target Aβ peptide aggregates as diagnostic tools for Alzheimer’s disease [PDF]
Bandara, Nilantha +6 more
core +2 more sources
Preclinical PET imaging of glycoprotein non-metastatic melanoma B in triple negative breast cancer: Feasibility of an antibody-based companion diagnostic agent [PDF]
Dehdashti, Farrokh +12 more
core +2 more sources
Potential role of 124I-girentuximab in the presurgical diagnosis of clear-cell renal cell cancer
Marc C Smaldone,1 David YT Chen,1 Jian Q Yu,2 Elizabeth R Plimack31Division of Urologic Oncology, 2Department of Diagnostic Imaging, 3Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USAAbstract: Renal cell carcinoma (RCC) is a ...
Plimack ER, Yu JQ, Chen DY, Smaldone MC
doaj
Synthesis and Evaluation of Pyridyloxypyridyl Indole Carboxamides as Potential PET Imaging Agents for 5-HT2C Receptors. [PDF]
Zeng F +4 more
europepmc +1 more source
Classics in Neuroimaging: Development of PET Tracers for Imaging Monoamine Oxidases. [PDF]
Narayanaswami V +7 more
europepmc +1 more source

